Sera Prognostics Inc (NASDAQ: SERA)’s stock price has gone rise by 9.17 in comparison to its previous close of 7.20, however, the company has experienced a -1.13% decrease in its stock price over the last five trading days. prnewswire.com reported 2024-09-04 that SALT LAKE CITY, Sept. 4, 2024 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the H.C.
Is It Worth Investing in Sera Prognostics Inc (NASDAQ: SERA) Right Now?
Company’s 36-month beta value is 1.03.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SERA is 19.74M, and currently, short sellers hold a 4.11% ratio of that floaft. The average trading volume of SERA on September 25, 2024 was 183.15K shares.
SERA’s Market Performance
The stock of Sera Prognostics Inc (SERA) has seen a -1.13% decrease in the past week, with a 5.79% rise in the past month, and a 40.36% gain in the past quarter. The volatility ratio for the week is 6.55%, and the volatility levels for the past 30 days are at 6.69% for SERA. The simple moving average for the past 20 days is 6.29% for SERA’s stock, with a 0.21% simple moving average for the past 200 days.
Analysts’ Opinion of SERA
Many brokerage firms have already submitted their reports for SERA stocks, with Citigroup repeating the rating for SERA by listing it as a “Neutral.” The predicted price for SERA in the upcoming period, according to Citigroup is $4 based on the research report published on March 30, 2022 of the previous year 2022.
Oppenheimer, on the other hand, stated in their research note that they expect to see SERA reach a price target of $19. The rating they have provided for SERA stocks is “Outperform” according to the report published on November 19th, 2021.
SERA Trading at 4.73% from the 50-Day Moving Average
After a stumble in the market that brought SERA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.38% of loss for the given period.
Volatility was left at 6.69%, however, over the last 30 days, the volatility rate increased by 6.55%, as shares surge +6.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.65% upper at present.
During the last 5 trading sessions, SERA fell by -1.13%, which changed the moving average for the period of 200-days by +43.17% in comparison to the 20-day moving average, which settled at $7.42. In addition, Sera Prognostics Inc saw 31.44% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SERA starting from Lindgardt Zhenya, who proposed sale 25,085 shares at the price of $7.57 back on Sep 10 ’24. After this action, Lindgardt Zhenya now owns shares of Sera Prognostics Inc, valued at $189,876 using the latest closing price.
Aerts Austin, the Officer of Sera Prognostics Inc, proposed sale 5,056 shares at $7.57 during a trade that took place back on Sep 10 ’24, which means that Aerts Austin is holding shares at $38,270 based on the most recent closing price.
Stock Fundamentals for SERA
Current profitability levels for the company are sitting at:
- -329.58 for the present operating margin
- -7.05 for the gross margin
The net margin for Sera Prognostics Inc stands at -294.72. The total capital return value is set at -0.59. Equity return is now at value -44.77, with -34.74 for asset returns.
Based on Sera Prognostics Inc (SERA), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -11.27. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -839.64.
Currently, EBITDA for the company is -38.62 million with net debt to EBITDA at 0.1. When we switch over and look at the enterprise to sales, we see a ratio of 2349.19. The receivables turnover for the company is 1.06for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.08.
Conclusion
In a nutshell, Sera Prognostics Inc (SERA) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
